KK
AUPH icon

Kotler Kevin’s Aurinia Pharmaceuticals AUPH Stock Holding History

Kotler Kevin’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$19.5M Buy
+1,224,846
New +$17.4M 4.57% 4

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Kotler Kevin's AUPH Position: Q4 2025 in Review

Kotler Kevin opened a new position in Aurinia Pharmaceuticals (AUPH) in Q4 2025: 1,224,846 shares worth $19.5M. The stake represents 4.57% of the portfolio and ranks #4 among its holdings.

255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • Kotler Kevin held 1,224,846 shares of Aurinia Pharmaceuticals worth $19.5M as of Q4 2025.
  • Aurinia Pharmaceuticals was a new Kotler Kevin position in Q4 2025.
  • Aurinia Pharmaceuticals made up 4.57% of Kotler Kevin's portfolio in Q4 2025, its #4 holding.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.